More than 1,500 nominations were received for the three Forbes 30 Under 30 lists in the DACH region for Germany, Austria, and Switzerland. A jury then compiled a list of the most influential people from the nominees. This includes founders, investors, activists, publicists, esports stars, and tennis pros. All are under the age of 30, have already achieved outstanding things, and are working on solutions with which they want to change the world for the better.
“This year, the Under 30 Listmakers are once again 90 exceptional young people from Germany, Austria and Switzerland who demonstrate the power of entrepreneurial thinking and innovative ideas to solve the major problems of our time,”
explained Klaus Fiala, Editor-in-Chief Forbes DACH.
Five Munich startup founders on the Forbes list
Five Munich residents are represented on this year's 30 Under 30 list for Germany:
There you will find Alexander Giesecke (25) and Nicolai Schork (26), founders and CEOs of Simpleclub. The Edtech startup offers over 3,000 learning videos, 5,000 exercises, and 850 summaries for grades 8 to 13. Simpleclub has been profitable since 2018, but recently secured two million euros from HV Capital for its further growth. VC investor explainedthat he would have liked to invest more, but the startup did not want more money from the investor.
Katharina Jünger (29), founded Teleclinic together with two colleagues and is CEO of the Munich-based company. The startup has a Online health platform launched, allowing patients to speak with a specialist from anywhere. Teleclinic saw significant growth in usage during the coronavirus crisis. In July, the Swiss Zur Rose Group – known in Germany for its pharmacy brand Docmorris – acquired Teleclinic.
Sebastian Pammer (28) and Stefan Fischer (28) are two of the five co-founders of Kumovis. Munich startup has developed a 3D printer with an integrated cleanroom environment specifically for medical technology. This printer produces, among other things, customized implants and is suitable for the series production of medical devices made of high-performance plastics. Just in June, Kumovis secured a €3.6 million Series A financing round.
